Congenital long QT syndrome 2 (LQT2) is caused by loss-offunction mutations in the humanCongenital Long QT Syndrome (LQTS) 2 is a disorder of the electrical system of the heart characterized by delayed cardiac repolarization that can lead to arrhythmias, syncope, and sudden death (1). Type 2 LQTS (LQT2) is caused by genetic mutations in the human ether-á-go-go-related gene (hERG) (2-5). hERG encodes the major subunit of the rapidly activating delayed-rectifier potassium current (I Kr ), which plays an essential role in the final repolarization of the ventricular action potential (3, 4). hERG exhibits characteristic slow closing (deactivation) kinetics that are regulated by an N-terminal PerArnt-Sim (PAS) domain, which help to specialize the channels for their role in the heart (3, 6 -10).Loss of hERG function, and thus, loss of I Kr (11), can occur through a number of mechanisms, including defects in channel opening and closing (gating), ion permeation, or protein trafficking (12). hERG channels containing LQT2 mutations in the PAS domain (hERG PAS-LQT2) exhibit robust currents when studied in Xenopus oocytes (6, 13-15); however, most channels with LQT2 mutations located outside the PAS domain do not have measurable currents and show defects in maturation and trafficking when studied in mammalian cells (12, 16 -21). As only 5 hERG PAS-LQT2 channels have been functionally characterized in mammalian cells (20 -24), the mechanism for how PAS domain mutations disrupt hERG function when expressed in more physiological conditions remains unclear.Previously, we showed that slow deactivation could be restored in LQT2 mutant hERG R56Q channels by application of a genetically encoded PAS domain (NPAS) in Xenopus oocytes (15). Here, we sought to determine whether NPAS was a general mechanism for rescue of LQT2 mutant channels. To carry out this goal we investigated 1) whether 11 different hERG PAS-LQT2 mutations that were gating deficient in Xenopus oocytes resulted in a loss-of-function in a human heterologous expression system and 2) whether NPAS could restore gating in several different hERG PAS-LQT2 mutant channels with gating defects in a mammalian system. We found that the 11 hERG PAS-LQT2 channels exhibited a spectrum of deficiencies in mammalian cells, and only channels with mutations located on one face of the PAS domain were gating deficient. These mutant channels exhibited an array of gating defects, including faster deactivation kinetics and a right-shift in the steady-state inactivation relationship, the combination of which resulted in aberrant currents in response to a dynamic ramp clamp. We found that NPAS rescued gating defects in hERG PAS-LQT2 channels by inducing slower deactivation kinetics and a left-shift in the steady-state inactivation relationship, which restored wild-type-like currents during the dynamic ramp clamp. Thus, NPAS restored function to channels that had a variety of gating defects. Therefore, in this study,